Imagine trying to see if a tiny seed is healthy without cracking it open. This technology acts like a super-powered magnifying glass that reads the chemical energy of a single cell without touching or harming it. It combines a signal booster and a tiny sensor to see exactly how a cell is functioning in real-time.
Current metabolic analysis methods cannot provide reliable data at the micro to picolitre scale without disrupting the cell. This creates a gap in IVF embryo selection and preclinical drug response monitoring.
A benchtop tool combining a hyperpolarization platform and a micro-NMR sensor capable of analyzing volumes down to 1 nL.
If you are an IVF clinic dealing with low pregnancy success rates — this project developed a non-invasive screening tool that selects the most viable embryos based on their metabolism. This helps improve the success rate of IVF for the one in six couples globally facing infertility.
If you are a biotech company dealing with slow preclinical drug testing — this project developed a metabolic assessment tool that monitors how individual cells respond to treatment. This optimizes the screening of drug candidates before moving to expensive trials.
If you are a diagnostic lab dealing with the inability to get reliable metabolic data at the picolitre scale — this project developed a benchtop micro-NMR device. It allows for the discovery of hidden disease mechanisms by profiling individual cells.
Based on available project data, the specific commercial price or implementation cost is not mentioned, though the project received an EU contribution of EUR 1,998,750 for development.
The project is developing a benchtop tool designed for integration into standard NMR systems, suggesting a path toward laboratory and clinical scale adoption.
Based on available project data, the technology is developed by a consortium of two SMEs, NVision Quantum Technologies and Annaida; specific licensing terms are not provided.
The project period runs from 2024-04-01 to 2026-09-30, indicating the timeline for optimization and validation of the integrated system.
The sensor head was specifically redesigned for successful integration into standard benchtop NMR systems with an easy sample loading mechanism.
The consortium is highly streamlined and commercially focused, consisting of 2 SMEs from Germany and Switzerland. With a 100% industry ratio, the project bypasses academic delays and focuses directly on the integration of two proprietary technologies: NVision's hyperpolarization platform and Annaida's micro-NMR sensors.
Contact NVision Quantum Technologies GmbH in Germany
Contact us to explore licensing opportunities for micro-NMR metabolic sensing.
